The Last Dance: Warren Buffett Doubles Down on These 2 Stocks

In This Article:

Warren Buffett, the legendary Oracle of Omaha, has confirmed that he’ll be stepping down as CEO of Berkshire Hathaway at the end of the year. While he’ll officially hand over the reins, investors are still watching his every move – especially as he takes what may be his final bold swings in the market.

Confident Investing Starts Here:

True to form, Buffett isn’t chasing hype. Instead, he’s reinforcing his long-held playbook: invest in companies with strong fundamentals, dependable dividends, and time-tested business models. That steady hand has earned him the title of the world’s most successful investor, and one of the richest people on the planet.

As his storied career nears its final chapter, Buffett is going out just as he came in: with conviction. He’s doubling down – literally – on two names in his portfolio, significantly increasing his stakes in both.

Using the TipRanks database, we’ve pulled together what Wall Street has to say about these two high-conviction picks. Let’s take a closer look.

Constellation Brands (STZ)

We’ll start with one of the beverage industry’s true stalwarts – and a new favorite investment of Buffett’s. Constellation Brands is a leader in the US market for alcoholic beverages, offering a large portfolio of beers, wines, and hard spirits for the consumer market. Constellation also holds the right to import the famous Mexican beer brands Modelo and Corona into the US; the company operates several breweries in Mexico to produce these beers for the import market. Modelo is the number-one imported beer in the US, and, since May of 2023, is the best-selling beer in the US; we should note that Corona is also in the top ten of best-selling beers, at number eight.

Among Constellation’s other brands, the Mexican import Pacifico is proving to be popular in California, while the company’s Modelo Chelada brand is finding favor with customers who prefer a more flavorful beverage.

Constellation’s stock has come under pressure this year. The company missed expectations in its 3Q25 earnings report, released in January, and as a major importer, the company is vulnerable to shifts in trade and tariff policy; against that background, the share price has remained depressed since the hit it took after the January earnings release.

In the most recent earnings report, released on April 9 and covering 4Q and full-year for fiscal 2025, Constellation reported $2.16 billion in quarterly sales, for a modest 0.9% year-over-year gain – a result that looked better after Q3’s 0.4% y/y sales drop. The Q4 revenue also beat the forecast by $40 million. At the bottom line, the company’s quarterly non-GAAP EPS of $2.63 was up 33 cents per share year-over-year and beat the forecast by 36 cents per share.